Research published last week in the journal Metabolites, found that glycerol monolaurate (GML), the primary active ingredient in ProlaeisTM and Optishield®, was one of two metabolites found in the breath of patients that could help distinguish between healthy people and COVID-infected patients. Natural Biologics’ research has demonstrated the anti-inflammatory and antiviral activity of GML. Published work with GML and African Swine Fever Virus completed by Natural Biologics was cited as evidence of GML’s efficacy in modulating the degree of inflammation and viral load in infected tissue. Read the complete Covid-19 research here. View the Natural Biologics GML study here.
